BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 33734961)

  • 1. Profile of specific antibodies to the SARS-CoV-2.
    Mou D; Feng H; Cao R; Weng X; Zhao L; Yang L; Jin R; Chen W
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33734961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
    Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X
    Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Over 1-year duration and age difference of SARS-CoV-2 antibodies in convalescent COVID-19 patients.
    Zeng F; Wu M; Wang J; Li J; Hu G; Wang L
    J Med Virol; 2021 Dec; 93(12):6506-6511. PubMed ID: 34170519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Combination of N and S Antigens With IgA and IgG Measurement Strengthens the Accuracy of SARS-CoV-2 Serodiagnostics.
    Jalkanen P; Pasternack A; Maljanen S; Melén K; Kolehmainen P; Huttunen M; Lundberg R; Tripathi L; Khan H; Ritvos MA; Naves R; Haveri A; Österlund P; Kuivanen S; Jääskeläinen AJ; Kurkela S; Lappalainen M; Rantasärkkä K; Vuorinen T; Hytönen J; Waris M; Tauriainen S; Ritvos O; Kakkola L; Julkunen I
    J Infect Dis; 2021 Jul; 224(2):218-228. PubMed ID: 33905505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric evaluation of clinical specificity and sensitivity of SARS-CoV-2 IgG and IgM serology assays.
    Bohn MK; Hall A; Wilson S; Taher J; Sepiashvili L; Adeli K
    Clin Chem Lab Med; 2021 May; 59(6):e235-e237. PubMed ID: 33577725
    [No Abstract]   [Full Text] [Related]  

  • 7. Longitudinal Profiling of Antibody Response in Patients With COVID-19 in a Tertiary Care Hospital in Beijing, China.
    Feng X; Yin J; Zhang J; Hu Y; Ouyang Y; Qiao S; Zhao H; Zhang T; Li X; Zhang L; Zhang J; Jin R; Feng Y; Su B
    Front Immunol; 2021; 12():614436. PubMed ID: 33790892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan.
    Yokoyama R; Kurano M; Morita Y; Shimura T; Nakano Y; Qian C; Xia F; He F; Kishi Y; Okada J; Yoshikawa N; Nagura Y; Okazaki H; Moriya K; Seto Y; Kodama T; Yatomi Y
    PLoS One; 2021; 16(3):e0247711. PubMed ID: 33661990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Declining Levels of Neutralizing Antibodies Against SARS-CoV-2 in Convalescent COVID-19 Patients One Year Post Symptom Onset.
    Xiang T; Liang B; Fang Y; Lu S; Li S; Wang H; Li H; Yang X; Shen S; Zhu B; Wang B; Wu J; Liu J; Lu M; Yang D; Dittmer U; Trilling M; Deng F; Zheng X
    Front Immunol; 2021; 12():708523. PubMed ID: 34220870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Serological Snapshot of COVID-19 Initial Stages in Israel by a 6-Plex Antigen Array.
    Fisher M; Levy H; Fatelevich E; Afrimov Y; Ben-Shmuel A; Rosenfeld R; Noy-Porat T; Glinert I; Sittner A; Biber A; Belkin A; Bar-David E; Puni R; Levy I; Mazor O; Weiss S; Mechaly A
    Microbiol Spectr; 2021 Oct; 9(2):e0087021. PubMed ID: 34612689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of Antibodies to Various Antigens of the SARS-CoV-2 Coronavirus in Patients with Confirmed COVID-19 Infection.
    Aleshkin AV; Novikova LI; Bochkareva SS; Kombarova SY; Lebedin YS; Vorob'ev AM; Mekhtiev ER; Zul'karneev ER; Laishevtsev AI; Karaulov AV
    Bull Exp Biol Med; 2021 May; 171(2):230-233. PubMed ID: 34173107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG Antibodies Develop to Spike but Not to the Nucleocapsid Viral Protein in Many Asymptomatic and Light COVID-19 Cases.
    Tutukina M; Kaznadzey A; Kireeva M; Mazo I
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence.
    Hartley GE; Edwards ESJ; Aui PM; Varese N; Stojanovic S; McMahon J; Peleg AY; Boo I; Drummer HE; Hogarth PM; O'Hehir RE; van Zelm MC
    Sci Immunol; 2020 Dec; 5(54):. PubMed ID: 33443036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG and IgM antibody formation to spike and nucleocapsid proteins in COVID-19 characterized by multiplex immunoblot assays.
    Shah J; Liu S; Potula HH; Bhargava P; Cruz I; Force D; Bazerbashi A; Ramasamy R
    BMC Infect Dis; 2021 Apr; 21(1):325. PubMed ID: 33827460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Not Available].
    Béguelin A
    Rev Med Suisse; 2021 Jan; 17(723):234. PubMed ID: 33507668
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of Anti-SARS-CoV-2 IgG Antibodies in Hemodialysis Patients Six Months after Infection.
    Sakhi H; Dahmane D; Attias P; Kofman T; Bouvier M; Lapidus N; Fourati S; El Karoui K;
    J Am Soc Nephrol; 2021 May; 32(5):1033-1036. PubMed ID: 33637518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of IgM and IgG Antibodies against SARS-CoV-2 in Asymptomatic People in Wuhan: Data from a General Hospital Near South China Seafood Wholesale Market during March to April in 2020.
    Ling RJ; Yu YH; He JY; Zhang JX; Xu S; Sun RR; Zhu WC; Chen MF; Li T; Ji HL; Wang HQ
    Biomed Environ Sci; 2021 Sep; 34(9):743-749. PubMed ID: 34530966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response dynamics in COVID-19 patients to SARS-CoV-2 and other human coronaviruses.
    Ravindran R; McReynolds C; Yang J; Hammock BD; Ikram A; Ali A; Bashir A; Zohra T; Chang WLW; Hartigan-O'Connor DJ; Rashidi HH; Khan IH
    PLoS One; 2021; 16(7):e0254367. PubMed ID: 34242356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray.
    Camerini D; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Shandling A; Huynh V; Teng AA; Hermanson G; Pablo JV; Stumpf MM; Lester SN; Harcourt J; Tamin A; Rasheed M; Thornburg NJ; Satheshkumar PS; Liang X; Kennedy RB; Yee A; Townsend M; Campo JJ
    Microbiol Spectr; 2021 Oct; 9(2):e0141621. PubMed ID: 34704808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.